These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 24130071)
1. Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma. Nadal E; Chen G; Gallegos M; Lin L; Ferrer-Torres D; Truini A; Wang Z; Lin J; Reddy RM; Llatjos R; Escobar I; Moya J; Chang AC; Cardenal F; Capellà G; Beer DG Clin Cancer Res; 2013 Dec; 19(24):6842-52. PubMed ID: 24130071 [TBL] [Abstract][Full Text] [Related]
2. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961 [TBL] [Abstract][Full Text] [Related]
3. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma. Daugaard I; Knudsen A; Kjeldsen TE; Hager H; Hansen LL Exp Mol Pathol; 2017 Jun; 102(3):484-491. PubMed ID: 28512015 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia. Ng HY; Wan TS; So CC; Chim CS J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488 [TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer. Wang Z; Chen Z; Gao Y; Li N; Li B; Tan F; Tan X; Lu N; Sun Y; Sun J; Sun N; He J Cancer Biol Ther; 2011 Mar; 11(5):490-6. PubMed ID: 21383543 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Kubo T; Toyooka S; Tsukuda K; Sakaguchi M; Fukazawa T; Soh J; Asano H; Ueno T; Muraoka T; Yamamoto H; Nasu Y; Kishimoto T; Pass HI; Matsui H; Huh NH; Miyoshi S Clin Cancer Res; 2011 Aug; 17(15):4965-74. PubMed ID: 21673066 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma. Hiroki E; Suzuki F; Akahira J; Nagase S; Ito K; Sugawara J; Miki Y; Suzuki T; Sasano H; Yaegashi N Int J Cancer; 2012 Aug; 131(4):E395-404. PubMed ID: 22052540 [TBL] [Abstract][Full Text] [Related]
9. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040 [TBL] [Abstract][Full Text] [Related]
10. miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Sato T; Shiba-Ishii A; Kim Y; Dai T; Husni RE; Hong J; Kano J; Sakashita S; Iijima T; Noguchi M Cancer Sci; 2017 Mar; 108(3):536-542. PubMed ID: 28012229 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma. Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602 [TBL] [Abstract][Full Text] [Related]
12. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma. Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516 [TBL] [Abstract][Full Text] [Related]
13. ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status. Tessema M; Yingling CM; Picchi MA; Wu G; Ryba T; Lin Y; Bungum AO; Edell ES; Spira A; Belinsky SA Cancer Lett; 2017 Dec; 410():191-200. PubMed ID: 28965852 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas. Supic G; Stefik D; Ivkovic N; Sami A; Zeljic K; Jovic S; Kozomara R; Vojvodic D; Stosic S Sci Rep; 2022 Jan; 12(1):1296. PubMed ID: 35079080 [TBL] [Abstract][Full Text] [Related]
15. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432 [TBL] [Abstract][Full Text] [Related]
16. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer. Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357 [TBL] [Abstract][Full Text] [Related]
17. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma. Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922 [TBL] [Abstract][Full Text] [Related]
18. The Methylation of the p53 Targets the Genes Voropaeva EN; Pospelova TI; Orlov YL; Churkina MI; Berezina OV; Gurazheva AA; Ageeva TA; Seregina OB; Maksimov VN Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011313 [TBL] [Abstract][Full Text] [Related]
19. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms. Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000 [TBL] [Abstract][Full Text] [Related]
20. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma. Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]